Article
An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.
Human molecular genetics - 15 Nov 2014
Gossage Lucy, Pires Douglas E V, Olivera-Nappa Álvaro, Asenjo Juan, Bycroft Mark, Blundell Tom L, Eisen Tim
Abstract excerpt
Mutations in the von Hippel-Lindau (VHL) gene are pathogenic in VHL disease, congenital polycythaemia and clear cell renal carcinoma (ccRCC). pVHL forms a ternary complex with elongin C and elongin B, critical for pVHL stability and function, which interacts with Cullin-2 and RING-box protein 1 to target hypoxia-inducible factor for polyubiquitination and proteasomal degradation. We describe a comprehensive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
